One of the most well-known examples is Epidermal Growth Factor Receptor (EGFR) mutations, present in 10–25% of NSCLC cases, more predominantly in adenocarcinomas, particularly among non-smokers, and more frequent in the Asian population [109]. This evidence concerns the gene EGFR and adenocarcinoma.